These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Sandborn WJ Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486 [No Abstract] [Full Text] [Related]
27. [Effects of immunosuppressive agents on renal and other changes in (NZBX NZW)F1 hybrid New Zealand mice]. Abe C; Shiokawa Y; Tanaka K Ryumachi; 1974 Mar; 14(1):43-52. PubMed ID: 4155127 [No Abstract] [Full Text] [Related]
29. [Auto-immune diseases and immunodepressive therapy. II. Current clinical indications]. Delespesse G; Kennes B; Duchateau J Acta Clin Belg; 1974; 29(6):413-23. PubMed ID: 4155218 [No Abstract] [Full Text] [Related]
30. [Purine analogues in autoimmune diseases--results of studies lasting several years]. Nelius D; Stieglitz R; Stobbe H; Apostoloff E; Reitzig P Z Gesamte Inn Med; 1973 Mar; 28(5):80 contd. PubMed ID: 4705903 [No Abstract] [Full Text] [Related]
31. [Results of immunosuppressive treatment of visceral lupus erythematosus]. Japa J; Kardaszewicz E Pol Tyg Lek; 1969 Oct; 24(40):1534-6. PubMed ID: 5365671 [No Abstract] [Full Text] [Related]
32. [Immunodepressive agents in neurology]. Sabouraud O Rev Prat; 1986 Jan; 36(5):229-36. PubMed ID: 2870559 [No Abstract] [Full Text] [Related]
33. [Our experiences with Imuran treatment]. Golacka K; Tarka Z Pol Tyg Lek; 1971 Mar; 26(10):345-6. PubMed ID: 5550676 [No Abstract] [Full Text] [Related]
34. [Use of immunosuppressive agents in systemic diseases]. Bétourné C Sem Hop; 1977 Jun; 53(24):1472-5. PubMed ID: 19844 [TBL] [Abstract][Full Text] [Related]
35. [Current status of immunosuppressive therapy in non-neoplastic disorders]. Grob PJ Schweiz Med Wochenschr; 1970 Apr; 100(16):703-7. PubMed ID: 4946733 [No Abstract] [Full Text] [Related]
36. [Immunosuppressive therapy in auto-immune diseases i. general fundamentals (author's transl)]. Sönnichsen N; Alberecht-Nebe H; Schulze P; Apostoloff E Dermatol Monatsschr; 1978 Nov; 164(11):769-78. PubMed ID: 363471 [No Abstract] [Full Text] [Related]
37. [Treatment of periarteritis nodosa using immunosuppressants and glucocorticoids]. Lüchtrath H; Weller O; Hammes P; Schaub R Med Welt; 1973 Jul; 24(27):1129-32. PubMed ID: 4148262 [No Abstract] [Full Text] [Related]
38. [Effectiveness of immunosuppressive agents in systemic lupus erythematosus. Comparative study of a series of 13 cases and of a control series of 12 cases]. Amor B; Kahan A; Pompidou A; Delbarre F Nouv Presse Med; 1972 Jun; 1(25):1699-702. PubMed ID: 5041721 [No Abstract] [Full Text] [Related]
39. Immunosuppressive therapy in neurological diseases. Cendrowski W; Riekkinen PJ; Rinne UK Ann Clin Res; 1974 Dec; 6(6):323-9. PubMed ID: 4375431 [No Abstract] [Full Text] [Related]
40. [Pharmacology of chemical immunosuppression]. Potel J; Brock N Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:339-57. PubMed ID: 5051958 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]